Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 1,818 citations
https://doi.org/10.1016/s0140-6736(21)00676-0
K
Karen Black
Turing Institute(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
44
Citations
3
h-index
2
i10-index
Karen Black is an academic researcher from Turing Institute. The author has contributed to research in topics: Legal case studies and regulations & Diverse Scientific and Economic Studies & Educational Robotics and Engineering. The author has an h-index of 3, co-authored 13 publications.
Papers by this author
worksMapping the human genetic architecture of COVID-19
2021 · Nature · 1,104 citations
https://doi.org/10.1038/s41586-021-03767-x
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(21)00149-5
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · The Lancet · 516 citations
https://doi.org/10.1016/s0140-6736(21)00897-7
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022 · Nature · 341 citations
https://doi.org/10.1038/s41586-022-04576-6
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · The Lancet · 320 citations
https://doi.org/10.1016/s0140-6736(22)01109-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat